Dr. Christopher H Chay
Claim this profileMessino Cancer Centers
Studies Lymphoma
Studies Lung Cancer
16 reported clinical trials
39 drugs studied
About Christopher H Chay
Education:
- Earned an MD from the University of North Carolina School of Medicine in 1995.
- Completed a Residency in Internal Medicine at the University of North Carolina Hospitals.
- Undertook a Fellowship in Hematology/Oncology at the University of Michigan Hospitals.
Experience:
- Board Certified in Hematology and Medical Oncology.
- Over 28 years of experience specializing in various types of cancer treatments.
- Practices at Messino Cancer Centers across Franklin, Asheville, and Sylva, North Carolina.
- Affiliated with Mission Hospital, Angel Medical Center, and Harris Regional Hospital.
Area of expertise
1Lymphoma
EZH2 positive
CNG positive
CNG negative
2Lung Cancer
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Christopher H Chay is currently running
Fuzuloparib + AA-P
for Prostate Cancer
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Recruiting1 award Phase 37 criteria
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
More about Christopher H Chay
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Christopher H Chay has experience with
- Atezolizumab
- Pembrolizumab
- Tazemetostat
- Rituximab
- Lenalidomide
- Adjuvant Chemotherapy
Breakdown of trials Christopher H Chay has run
Lymphoma
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher H Chay specialize in?
Christopher H Chay focuses on Lymphoma and Lung Cancer. In particular, much of their work with Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is Christopher H Chay currently recruiting for clinical trials?
Yes, Christopher H Chay is currently recruiting for 4 clinical trials in Asheville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Christopher H Chay has studied deeply?
Yes, Christopher H Chay has studied treatments such as Atezolizumab, Pembrolizumab, Tazemetostat.
What is the best way to schedule an appointment with Christopher H Chay?
Apply for one of the trials that Christopher H Chay is conducting.
What is the office address of Christopher H Chay?
The office of Christopher H Chay is located at: Messino Cancer Centers, Asheville, North Carolina 28806 United States. This is the address for their practice at the Messino Cancer Centers.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.